Answers are grounded in this paper and cite their sources.
Psoriasis is a multifactorial skin disorder with known systemic consequences. While most recent studies point to a predominantly Th17-driven process, psoriasis also lies at the crossroads linking the pathways of angiogenesis and inflammation. Mediators such as VEGF and angiopoietin-2 play significant roles in the pathophysiology and may even account for the maintenance of the chronic inflammatory state. Targets in this shared pathway may offer alternative avenues for therapy.
No takes yet. Share an insight, caveat, or question.
Chua et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: